Medigene (MDG1) Stock Chart & Stock Price History → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free MDG1 Stock Alerts €1.60 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share ChartStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Medigene Stock Price Performance5 Day Performance-16.93%1 Month Performance-32.42%3 Month Performance+10.76%6 Month Performance+2.57%Year-To-Date Performance+4.59%1 Year Performance-11.39% Receive MDG1 Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medigene and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. MDG1 Stock Chart for Friday, April, 26, 2024 MDG1 Chart by TradingView Medigene Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024€1.59€1.59€1.74€1.5442,373 shs$39.05 million04/24/2024€1.72€1.59-7.56%€1.74€1.5442,373 shs$39.05 million04/23/2024€1.92€1.72-10.42%€1.89€1.61114,079 shs$42.24 million04/22/2024€1.92€1.92€1.94€1.835,805 shs$47.16 million04/19/2024€1.85€1.92+4.07%€1.94€1.835,805 shs$47.16 million04/18/2024€1.97€1.85-6.35%€1.91€1.7632,043 shs$45.31 million Get the Latest News and Ratings for MDG1 and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medigene and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024€2.01€1.97-1.99%€2.00€1.9027,614 shs$48.38 million04/16/2024€2.06€2.01-2.43%€2.05€1.9020,340 shs$49.37 million04/15/2024€2.06€2.06€2.19€2.007,677 shs$50.59 million04/12/2024€2.13€2.06-3.29%€2.19€2.007,677 shs$50.59 million04/11/2024€2.13€2.13€2.19€1.9823,493 shs$52.31 million04/10/2024€2.13€2.13€2.24€2.0318,277 shs$52.31 million04/09/2024€2.17€2.13-1.84%€2.24€2.0318,277 shs$52.31 million04/08/2024€2.17€2.17€2.24€2.0724,557 shs$53.30 million04/05/2024€2.04€2.17+6.37%€2.24€2.0724,557 shs$53.30 million04/04/2024€2.19€2.04-6.85%€2.15€1.9133,572 shs$50.10 million04/03/2024€2.11€2.19+3.79%€2.19€2.0717,710 shs$53.79 million04/02/2024€2.11€2.11€2.28€1.92123,601 shs$51.82 million04/01/2024€2.11€2.11€2.28€1.92123,601 shs$51.82 million03/29/2024€2.12€2.11-0.47%€2.28€1.92123,601 shs$51.82 million03/28/2024€2.36€2.12-10.17%€2.44€2.1256,527 shs$52.07 million03/27/2024€2.36€2.36€2.84€2.31171,348 shs$57.96 million03/26/2024€2.35€2.36+0.43%€2.84€2.31171,348 shs$57.96 million03/25/2024€2.35€2.35€2.80€2.08191,378 shs$57.72 million03/22/2024€1.70€2.00+17.65%€2.00€1.6978,444 shs$49.12 million03/21/2024€1.66€1.70+2.72%€1.76€1.6113,628 shs$41.75 million03/20/2024€1.74€1.66-4.89%€1.80€1.6139,417 shs$40.65 million03/19/2024€1.62€1.74+7.41%€1.80€1.6162,713 shs$42.73 million03/18/2024€1.62€1.62€1.70€1.4849,811 shs$39.79 million03/15/2024€1.46€1.46-0.34%€1.52€1.468,072 shs$35.74 million03/14/2024€1.50€1.46-2.67%€1.56€1.4613,188 shs$35.86 million03/13/2024€1.46€1.50+3.09%€1.56€1.4617,723 shs$36.84 million03/12/2024€1.51€1.46-3.64%€1.48€1.461,537 shs$35.74 million03/11/2024€1.51€1.51€1.56€1.516,004 shs$37.09 million03/08/2024€1.55€1.52-1.94%€1.58€1.526,153 shs$37.21 million03/07/2024€1.55€1.55€1.55€1.5161 shs$37.95 million03/06/2024€1.53€1.55+0.98%€1.55€1.5161 shs$37.95 million03/05/2024€1.52€1.53+0.66%€1.59€1.452,768 shs$37.58 million03/04/2024€1.52€1.52€1.63€1.4619,418 shs$37.33 million03/01/2024€1.45€1.47+1.03%€1.58€1.465,981 shs$35.98 millionThe Next Step of Their Control Is Here … (Ad)Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late.02/29/2024€1.50€1.45-3.33%€1.50€1.454,958 shs$35.61 million02/28/2024€1.51€1.50-0.33%€1.54€1.466,871 shs$36.84 million02/27/2024€1.58€1.51-4.44%€1.58€1.472,740 shs$36.96 million02/26/2024€1.58€1.58€1.60€1.509,098 shs$38.68 million02/23/2024€1.54€1.64+6.84%€1.64€1.51760 shs$40.28 million02/22/2024€1.54€1.54€1.64€1.509,645 shs$37.70 million02/21/2024€1.55€1.54-0.65%€1.64€1.509,645 shs$37.70 million02/20/2024€1.55€1.55€1.65€1.486,950 shs$37.95 million02/19/2024€1.56€1.55-0.64%€1.65€1.486,950 shs$37.95 million02/16/2024€1.59€1.59€1.60€1.557,025 shs$38.93 million02/15/2024€1.56€1.59+1.60%€1.60€1.557,025 shs$38.93 million02/14/2024€1.59€1.56-1.89%€1.62€1.5211,302 shs$38.31 million02/13/2024€1.49€1.59+7.07%€1.65€1.4938,299 shs$39.05 million02/12/2024€1.49€1.49€1.62€1.494,349 shs$36.47 million02/09/2024€1.55€1.55€1.60€1.5112,983 shs$38.07 million02/08/2024€1.63€1.55-4.91%€1.60€1.5112,983 shs$38.07 million02/07/2024€1.45€1.63+12.41%€1.77€1.4660,588 shs$40.03 million02/06/2024€1.47€1.45-1.02%€1.48€1.3916,516 shs$35.61 million02/05/2024€1.47€1.47€1.50€1.4016,468 shs$35.98 million02/02/2024€1.47€1.47€1.50€1.3916,773 shs$35.98 million02/01/2024€1.49€1.47-1.35%€1.50€1.3916,773 shs$35.98 million01/31/2024€1.39€1.49+7.22%€1.50€1.4015,359 shs$36.47 million01/30/2024€1.41€1.39-1.77%€1.43€1.395,696 shs$34.02 million01/29/2024€1.45€1.41-2.42%€1.41€1.394,315 shs$34.63 million01/26/2024€1.41€1.44+2.13%€1.45€1.413,685 shs$35.37 million01/25/2024€1.44€1.41-2.08%€1.42€1.411,683 shs$34.63 million Related Companies: Genfit Stock Chart Biotest Aktiengesellschaft Stock Chart MorphoSys Stock Chart Fielmann Group Stock Chart Fresenius SE & Co. KGaA Stock Chart Sanofi Stock Chart Sartorius Aktiengesellschaft Stock Chart Sartorius Stedim Biotech Stock Chart Drägerwerk AG & Co. KGaA Stock Chart Stratec Stock Chart Receive MDG1 Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Medigene and its competitors with MarketBeat's FREE daily newsletter. This page (ETR:MDG1) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medigene AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.